Clinical practice. Recurrent miscarriage, N Engl J Med, vol.363, pp.1740-1747, 2010. ,
Embryonic karyotype of abortuses in relation to the number of previous miscarriages, Fertil Steril, vol.73, pp.300-304, 2000. ,
Thrombophilic disorders and fetal loss: a meta-analysis, Lancet, vol.361, pp.901-909, 2003. ,
The thrombomodulin-protein C system is essential for the maintenance of pregnancy, Nat. Med, vol.9, pp.331-338, 2003. ,
Extraembryonic expression of EPCR is essential for embryonic viability, Blood, vol.106, pp.2716-2738, 2005. ,
Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight, Thromb Haemost, vol.85, pp.18-21, 2001. ,
whole-blood haemostasis and recurrent miscarriage, Hum Reprod, vol.18, pp.2540-2543, 2003. ,
Increased thrombin generation measured in the presence of thrombomodulin in women with early pregnancy loss, Fertil Steril, vol.95, pp.1813-1818, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00721941
Unexplained pregnancy loss: a marker of basal endothelial dysfunction?, Fertil Steril, vol.100, pp.1013-1020, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00935486
Pregnancy loss and risk of cardiovascular disease: a prospective population-based cohort study (EPIC-Heidelberg), Heart, vol.97, pp.49-54, 2011. ,
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage, N Engl J Med, vol.362, pp.1586-96, 2010. ,
SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage, Blood, vol.115, pp.4162-4169, 2010. ,
Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial, Thromb Haemost, vol.105, pp.295-301, 2011. ,
Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial, Blood, vol.125, pp.2200-2205, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01275892
Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial, 16. van den Boogaard E, vol.384, pp.605-624, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01258557
Recurrent miscarriage, Lancet, vol.368, pp.601-612, 2006. ,
The T helper type 17/regulatory T cell paradigm in pregnancy, Immunology, vol.148, pp.13-21, 2016. ,
Excessive TLR9 signaling contributes to the pathogenesis of spontaneous abortion through impairment of Treg cell survival by activation of Caspase 8/3, Int Immunopharmacol, vol.29, pp.285-92, 2015. ,
Immunotherapy for recurrent miscarriage, Cochrane Database Syst Rev, vol.2, p.112, 2006. ,
The effects of intravenous immunoglobulins in women with recurrent miscarriages: a systematic review of randomised trials with meta-analyses and trial sequential analyses including individual patient data, PLoS One, vol.10, p.141588, 2015. ,
A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant, Hum Reprod, vol.28, pp.1743-52, 2013. ,
Recurrent miscarriage--outcome after supportive care in early pregnancy, Aust N Z J Obstet Gynaecol, vol.31, pp.320-322, 1991. ,
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), J Thromb Haemost, vol.4, pp.295-306, 2006. ,
Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial, J Rheumatol, vol.36, pp.279-87, 2009. ,
Does hydroxychloroquine sulfate prevent clot formation in systemic lupus erythematosus?, Arthritis Rheum, vol.30, pp.1435-1441, 1987. ,
Clinical and experimental evaluation of the thromboprophylactic effect of hydroxychloroquine sulfate after total hip replacement, Haemostasis, vol.10, pp.89-96, 1981. ,
Hydroxychloroquine in prophylaxis of pulmonary embolism following hip arthroplasty, Clin Orthop Relat Res, vol.144, pp.174-181, 1979. ,
Prevention of postoperative deep venous thrombosis in legs by orally administered hydroxychloroquine sulphate, Br Med J, vol.3, pp.94-99, 1974. ,
Prophylaxis of deep venous thrombosis by hydroxychloroquine sulfate and heparin, Surg Gynecol Obstet, vol.145, pp.714-722, 1977. ,
Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus, Lupus, vol.15, pp.577-83, 2006. ,
Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies, Arthritis Rheum, vol.61, pp.29-36, 2009. ,
The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus, Arthritis Rheum, vol.62, pp.863-871, 2010. ,
Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice, Circulation, vol.96, pp.4380-4384, 1997. ,
Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients, J Thromb Haemost, vol.11, issue.9, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02347272
Use of antimalarial drugs as "desludging" agents in vascular disease processes, J Am Med Assoc, vol.172, pp.1630-1633, 1960. ,
Modification of transoperative changes in blood fluidity by hydroxychloroquine: a possible explanation for the drug's antithrombotic effect, Pharmatherapeutica, vol.4, pp.48-52, 1984. ,
Prevention of postoperative deep venous thrombosis and pulmonary embolism, Br Med J, vol.1, pp.312-316, 1971. ,
Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies, Thromb Haemost, vol.87, pp.518-540, 2002. ,
Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers, Blood, vol.112, pp.1687-95, 2008. ,
The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas--a randomized trial, Diabetes Res Clin Pract, vol.55, pp.209-228, 2002. ,
Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis, Am J Med, vol.96, pp.254-263, 1994. ,
Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus, Arthritis Res Ther, vol.17, p.277, 2015. ,
Identification of activators of ERK5 transcriptional activity by high-throughput screening and the role of endothelial ERK5 in vasoprotective effects induced by statins and antimalarial agents, J Immunol, vol.193, pp.3803-3818, 2014. ,
Antimalarial agents: closing the gate on Toll-like receptors?, Arthritis Rheum, vol.54, pp.3068-70, 2006. ,
Mode of action of hydroxychloroquine in RA-evidence of an inhibitory effect on toll-like receptor signaling, Nat Clin Pract Rheumatol, vol.2, pp.458-467, 2006. ,
Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines, J Immunol, vol.186, pp.4794-804, 2011. ,
Effect of antimalarial drugs on stimulation and interleukin 2 production of human lymphocytes, Int J Immunopharmacol, vol.9, pp.513-522, 1987. ,
Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells, J Rheumatol, vol.24, pp.55-60, 1997. ,
Chloroquine interferes with lipopolysaccharide-induced TNF-alpha gene expression by a nonlysosomotropic mechanism, J Immunol, vol.165, pp.1534-1574, 2000. ,
Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosus, J Rheumatol, vol.40, pp.30-33, 2013. ,
Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome, Lupus, vol.17, pp.938-981, 2008. ,
Human antiphospholipid antibodies induce TNFalpha in monocytes via Toll-like receptor 8, Immunobiology, vol.215, pp.230-271, 2010. ,
, , 2019.
TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss, J Immunol, vol.174, pp.485-90, 2005. ,
Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis, Br J Clin Pharmacol, vol.81, pp.835-883, 2016. ,
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation, Ann Rheum Dis, vol.75, pp.795-810, 2016. ,
,
, Therapie, vol.68, pp.43-50, 2013.
A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage, Hum Reprod, vol.14, pp.2868-71, 1999. ,
The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a european multicenter retrospective study, Autoimmun Rev, vol.14, pp.498-502, 2015. ,
, , 2019.